MedMira Inc V.MIR

Alternate Symbol(s): MMIRF

Healthcare Medical Devices

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. It provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.

TSXV:MIR - Post by User

MedMira Inc > REALITY CHECK FOR MEDMIRA MANAGEMENT

<< Previous

Bullboard Posts

Next >>

Comment by goldyhawkon Apr 08, 2024 9:38am

110 Views

Post# 35976470

RE:RE:RE:RE:RE:REALITY CHECK FOR MEDMIRA MANAGEMENT

Just a bit more information about the irons in the fire etc might persuade me and others to buy more stock in Medmira

I have already extended considerable with this company and deserve an opportunity to know a bit more before investing more

The company should have no qualms about helping shareholders buy more and profit more
The lack of clarity offers no incentive to invest more in Medmira

<< Previous

Bullboard Posts

Next >>

Nvidia reports record revenue in Q3